Actively Recruiting
Evaluation of Giredestrant Treatment Adherence and Patient Outcomes in Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer A Phase IIIb, Single-Arm, Open-Label Multicenter Study
Led by Hoffmann-La Roche · Updated on 2026-11-03
1500
Participants Needed
1
Research Sites
208 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying how well participants with estrogen receptor-positive, HER2-negative early breast cancer tolerate and adhere to treatment with giredestrant. The study focuses on two groups one with a broad range of risk levels and another switching to giredestrant after previous treatment with specific cancer therapies. This phase IIIb trial aims to understand treatment adherence, tolerability, and patient-reported outcomes. Participants will receive giredestrant 30 mg orally once daily for up to five years. The study includes two cohorts Cohort A with patients newly treated with adjuvant endocrine therapy, and Cohort B with patients switching to giredestrant after prior cyclin-dependent kinase 4 and 6 inhibitor therapy. Both groups will be monitored throughout the treatment period. Participants will have regular assessments to track treatment adherence, side effects, and quality of life using questionnaires like FACT-ES and BPI-SF. Researchers will measure outcomes such as treatment discontinuation rates at 12 months and monitor adverse events for up to five years. The study also evaluates changes in symptoms like joint pain, hot flashes, and sexual dysfunction, supporting comprehensive understanding of patient experiences during treatment.
CONDITIONS
Brief Title
A Study to Learn How Well Participants With a Specific Type of Early Breast Cancer (ER-Positive, HER2-Negative) Tolerate and Stay on Treatment With Giredestrant and How They Feel During Treatment
Research Team
R
Reference Study ID Number: BO46775 https://forpatients.roche.com/ No attachments to email below.
F
Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here